2019
DOI: 10.26508/lsa.201900431
|View full text |Cite
|
Sign up to set email alerts
|

Targeting plasma membrane phosphatidylserine content to inhibit oncogenic KRAS function

Abstract: The small GTPase KRAS, which is frequently mutated in human cancers, must be localized to the plasma membrane (PM) for biological activity. We recently showed that the KRAS C-terminal membrane anchor exhibits exquisite lipid-binding specificity for select species of phosphatidylserine (PtdSer). We, therefore, investigated whether reducing PM PtdSer content is sufficient to abrogate KRAS oncogenesis. Oxysterol-related binding proteins ORP5 and ORP8 exchange PtdSer synthesized in the ER for phosphatidyl-4-phosph… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
45
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 35 publications
(49 citation statements)
references
References 54 publications
0
45
0
Order By: Relevance
“…1 for possible modes of increasing nuclear GAL4/VP16-KRAS4B). Because the asymmetric distribution of phosphatidylserine (PS) in the PM has been shown to produce the negative charge that stabilizes KRAS4B association (26), we expected to find genes involved in PS metabolism or transport (27). The only gene in these pathways that scored consistently positive, albeit without passing our stringent RIGER analysis, was PI4KIIIα, which is responsible for generating the pool of PI4P at the PM that is exchanged with PS generated in the ER (28).…”
Section: Discussionmentioning
confidence: 99%
“…1 for possible modes of increasing nuclear GAL4/VP16-KRAS4B). Because the asymmetric distribution of phosphatidylserine (PS) in the PM has been shown to produce the negative charge that stabilizes KRAS4B association (26), we expected to find genes involved in PS metabolism or transport (27). The only gene in these pathways that scored consistently positive, albeit without passing our stringent RIGER analysis, was PI4KIIIα, which is responsible for generating the pool of PI4P at the PM that is exchanged with PS generated in the ER (28).…”
Section: Discussionmentioning
confidence: 99%
“…This supports the idea that any deregulation of ORP5 can distort the signaling capacity of the cell by changing the lipid content of the PM. Corroborating this, a lack of ORP5/8 activity was found to result in lower PS abundance in the PM, reducing the oncogenicity of K-Ras, a signaling protein that is frequently mutated in human cancers (Kattan et al, 2019).…”
Section: Roles Of Ps/pi(4)p Exchange In Other Cellular Regions and Inmentioning
confidence: 85%
“…Finally, it is also tempting to speculate that the tight regulation of PM PI(4,5)P2 by ORP5/8 could contribute to the ORP8 influence on AKT signaling [ 30 , 45 , 46 ], as this could conceivably also impact the synthesis of PI(3,4,5)P3 by PI3K. Indeed, recently, the depletion of ORP5 or ORP8 reduced PM PS levels resulting in mislocalization of KRas from the PM, an oncogene that requires PM PS for its localization and activity [ 72 ]. Together with effects on Ca 2+ signaling [ 64 ], these are both additional mechanisms based on phospholipid transfer through which ORP5/8 may contribute to the control of proliferation, migration and other functions.…”
Section: Discussionmentioning
confidence: 99%